Progress of the targeted tumor therapy with α-emitting nuclides

ZAN Liangbiao LIU Ning YANG Yuanyou JIN Jiannan

doi:null

您当前的位置：

首页 >

文章列表页 >

Progress of the targeted tumor therapy with α-emitting nuclides

更新时间：2021-03-12

- Progress of the targeted tumor therapy with α-emitting nuclides
- NUCLEAR TECHNIQUES Issue 4, (2006)
- 作者机构：
  
  1. 四川大学原子核科学技术研究所辐射物理及技术教育部重点实验室
  2. 四川大学原子核科学技术研究所辐射物理及技术教育部重点实验室,成都,610064
- 作者简介：
- 基金信息：
- DOI：
  CLC： R730.5
- Published：01 April 2006
- 稿件说明：
移动端阅览
[1]昝亮彪,刘宁,杨远友,金建南.α核素用于肿瘤靶向治疗研究的进展[J].核技术,2006(04):279-285.

ZAN Liangbiao LIU Ning YANG Yuanyou JIN Jiannan. Progress of the targeted tumor therapy with α-emitting nuclides[J]. Nuclear techniques, 2006, (4): 279-285.
[1]昝亮彪,刘宁,杨远友,金建南.α核素用于肿瘤靶向治疗研究的进展[J].核技术,2006(04):279-285. DOI：

ZAN Liangbiao LIU Ning YANG Yuanyou JIN Jiannan. Progress of the targeted tumor therapy with α-emitting nuclides[J]. Nuclear techniques, 2006, (4): 279-285. DOI：

摘要

α核素具有极强的放射生物学效应和细胞毒性作用

特别对散在性癌和微转移癌的内放射治疗具有良好的应用前景。本文介绍了目前国内外一些研究比较活跃的α治疗核素用于肿瘤靶向治疗研究的新进展

对于存在的问题、现状及临床应用前景也进行了探讨。

Abstract

α-emitting nuclides are considered as very attractive in cancer therapy due to their strong radiobiological characteristics and cytotoxicity

especially for disseminated and micrometastatic tumors. In this paper

progress of the targeted tumor therapy with α-emitting nuclides are reviewed with 65 references. In addition

its present situation

problems and prospect are also discussed.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Preparation of ¹³¹I-23-hydroxybetulinic acid and in vivo evaluations in liver cancer HepA tumor-bearing mice

Synthesis and biological property evaluation of ⁹⁰Y radiolabeled glycosylated somatostatin

Preparation of 3H-23-hydroxylbetulinic acid and in vivo evaluations in mice

Applications of ¹⁸F-FDG imaging with a dual head coincidence SPECT/CT in the detection of tumors

Effects of IL-6 on proliferation and apoptosis of tumor cells multi-irradiated for tumor-bearing mice

Related Author

YANG Min1 WANG Guangji2 XU Yuping1 PAN Donghui1 WANG Songpei1 LI Xiaomin1 TANG Jie1 LUO Shineng1 1

罗世能

唐婕

李晓敏

王颂佩

潘栋辉

徐宇平

王广基

Related Institution

Jiangsu Institute of Nuclear Medicine, Key Laboratory of Nuclear Medicine, Ministry of Health, Wuxi 214063, China) 2

中国药科大学

Department of Biophysics, School of Basic Medical Science, Peking University, Beijing 100083) 2

中国原子能科学研究院同位素研究所

北京大学基础医学院生物物理系

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：881139 Visits Today：666

⁰